Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richman

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
The Journal of Clinical Investigation|November 16, 2013
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expressionChristian Mueller, Jeffrey D Chulay, Bruce C Trapnell, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
The Journal of Clinical Investigation|February 11, 2021
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Immunity|July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to ImmunotherapyJinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
BMJ Open|September 19, 2020
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North AmericaJoshua D Green, Richard J Barohn, Emanuela Bartoccion, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|February 22, 2022
Surgical stabilization versus nonoperative treatment for flail and non-flail rib fracture patterns in patients with traumatic brain injuryJonne T H Prins, Esther M M Van Lieshout, Francis Ali-Osman, et al.
The Journal of Trauma and Acute Care Surgery|October 23, 2020
Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI)Jonne T H Prins, Esther M M Van Lieshout, Francis Ali-Osman, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
The Journal of Clinical Investigation|November 16, 2013
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expressionChristian Mueller, Jeffrey D Chulay, Bruce C Trapnell, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
The Journal of Clinical Investigation|February 11, 2021
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
The Journal of Clinical Investigation|May 1, 2024
CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replicationPablo Tebas, Julie K Jadlowsky, Pamela A Shaw, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Immunity|July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to ImmunotherapyJinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
BMJ Open|September 19, 2020
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North AmericaJoshua D Green, Richard J Barohn, Emanuela Bartoccion, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|February 22, 2022
Surgical stabilization versus nonoperative treatment for flail and non-flail rib fracture patterns in patients with traumatic brain injuryJonne T H Prins, Esther M M Van Lieshout, Francis Ali-Osman, et al.
The Journal of Trauma and Acute Care Surgery|October 23, 2020
Outcome after surgical stabilization of rib fractures versus nonoperative treatment in patients with multiple rib fractures and moderate to severe traumatic brain injury (CWIS-TBI)Jonne T H Prins, Esther M M Van Lieshout, Francis Ali-Osman, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 21